Form 4: ACMR CFO Sells Stock Under 10b5-1 Plan

ACM Research CFO Mark McKechnie exercised options and sold Class A Common Stock in planned transactions.

Summary

• ACM Research, Inc. (ACMR) Chief Financial Officer and Treasurer, Mark McKechnie, reported transactions involving Class A Common Stock.
• The transactions, which included both option exercises and subsequent stock sales, occurred on December 4, 2025, and December 8, 2025.
• All sales were executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. McKechnie on August 27, 2025.
• On December 4, 2025, Mr. McKechnie exercised 8,750 stock options at an exercise price of $4.55 per share.
• Following this exercise, he sold 7,754 shares of Class A Common Stock at a weighted average price of $33.50 per share and an additional 996 shares at a weighted average price of $34.26 per share.
• On December 8, 2025, Mr. McKechnie exercised 22,500 stock options at an exercise price of $25.45 per share.
• Subsequently, he sold 22,500 shares of Class A Common Stock at a price of $35.45 per share.
• Following all reported transactions, Mr. McKechnie's direct beneficial ownership of Class A Common Stock is 900 shares.

Sentiment

Score: 5

Explanation: The filing reports routine insider transactions (option exercises and sales) executed under a pre-arranged 10b5-1 plan, which is a neutral event for the company's operational performance. While significant sales by an executive can sometimes be viewed negatively, the pre-planned nature mitigates immediate concerns about future company performance.

Positives

• The CFO realized significant gains from the exercise of stock options and subsequent sale of shares.

Negatives

• The CFO sold a substantial number of shares, reducing his direct beneficial ownership to 900 Class A Common Stock shares.

Risks

• Potential negative market perception due to significant insider selling by a key executive, even if executed under a pre-arranged 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports routine insider transactions and does not provide information related to broader industry trends or competitive landscape.

Stakeholder Impact

• Shareholders: May interpret the significant sales by a key executive differently; some might view it as routine diversification, while others might perceive it as a lack of confidence, potentially influencing short-term trading sentiment.

Key Dates

Keywords

ACM Research, ACMR, Form 4, insider trading, stock options, CFO, stock sale, 10b5-1 plan